China Universal Asset Management Company’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.3K | Buy |
32,501
+402
| +1% | +$288 | ﹤0.01% | 450 |
|
2025
Q1 | $47.2K | Sell |
32,099
-1,833
| -5% | -$2.7K | ﹤0.01% | 422 |
|
2024
Q4 | $150K | Buy |
33,932
+3,209
| +10% | +$14.2K | 0.01% | 351 |
|
2024
Q3 | $127K | Buy |
30,723
+12,047
| +65% | +$49.6K | 0.01% | 339 |
|
2024
Q2 | $122K | Sell |
18,676
-11,415
| -38% | -$74.4K | 0.02% | 289 |
|
2024
Q1 | $262K | Buy |
30,091
+12,030
| +67% | +$105K | 0.03% | 258 |
|
2023
Q4 | $207K | Buy |
18,061
+14,064
| +352% | +$161K | 0.04% | 202 |
|
2023
Q3 | $38.5K | Buy |
3,997
+1,961
| +96% | +$18.9K | 0.01% | 246 |
|
2023
Q2 | $21.7K | Sell |
2,036
-53
| -3% | -$564 | 0.01% | 259 |
|
2023
Q1 | $22K | Buy |
2,089
+531
| +34% | +$5.59K | 0.01% | 207 |
|
2022
Q4 | $19.3K | Buy |
1,558
+123
| +9% | +$1.52K | 0.01% | 175 |
|
2022
Q3 | $15K | Buy |
+1,435
| New | +$15K | 0.01% | 172 |
|